These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 19196196)
1. Experience with pneumococcal conjugate vaccine in Norway. Aaberge IS Expert Rev Vaccines; 2009 Feb; 8(2):159-65. PubMed ID: 19196196 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376 [TBL] [Abstract][Full Text] [Related]
3. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206 [TBL] [Abstract][Full Text] [Related]
5. Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Andersen PH; Howitz M; Krogfelt KA; Lambertsen L; Konradsen HB Vaccine; 2010 Mar; 28(14):2642-7. PubMed ID: 20096392 [TBL] [Abstract][Full Text] [Related]
6. Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children. Paradiso PR Clin Infect Dis; 2011 May; 52(10):1241-7. PubMed ID: 21507921 [TBL] [Abstract][Full Text] [Related]
7. Has the seven-valent pneumococcal conjugate vaccine had an impact on invasive pneumococcal disease in Western Australia? Giele C; Moore H; Bayley K; Harrison C; Murphy D; Rooney K; Keil AD; Lehmann D Vaccine; 2007 Mar; 25(13):2379-84. PubMed ID: 17064825 [TBL] [Abstract][Full Text] [Related]
8. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956 [TBL] [Abstract][Full Text] [Related]
11. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Rückinger S; van der Linden M; Reinert RR; von Kries R; Burckhardt F; Siedler A Vaccine; 2009 Jun; 27(31):4136-41. PubMed ID: 19406190 [TBL] [Abstract][Full Text] [Related]
12. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):258-61. PubMed ID: 20224542 [TBL] [Abstract][Full Text] [Related]
14. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe. Rose M; Zielen S Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758 [TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations. Adam D; Fehnle K Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402 [TBL] [Abstract][Full Text] [Related]
16. Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population. Temime L; Boelle PY; Opatowski L; Guillemot D PLoS One; 2008 Sep; 3(9):e3244. PubMed ID: 18802466 [TBL] [Abstract][Full Text] [Related]
17. Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1148-51. PubMed ID: 18946462 [TBL] [Abstract][Full Text] [Related]
19. Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule. Vestrheim DF; Høiby EA; Bergsaker MR; Rønning K; Aaberge IS; Caugant DA Vaccine; 2010 Mar; 28(10):2214-2221. PubMed ID: 20056192 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of 7-valent pneumococcal conjugate vaccination in Germany: An analysis using the indirect cohort method. Rückinger S; van der Linden M; Reinert RR; von Kries R Vaccine; 2010 Jul; 28(31):5012-6. PubMed ID: 20546832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]